ANATOMIC AND MORPHOLOGICAL SIGNS OF A DIFFUSE-GENERALIZED HYPERTROPHIC CARDIOMYOPATHY

Aim. Based on the instrumental, histological and genetic studies to show the role and significance of intracardial anomalies and morphological specifics of the special form of hypertrophic cardiomyopathy (HCM), that the authors name as diffuse-generalized. Material and methods. A clinical, instrumental, histological and molecular-genetic study was conducted with 16 enrolled patients with diffuse-generalized form of HCM, who underwent complex surgical interventions: by transaortal approach the extended myoectomy of interventricular sept, and by intraatrial approach — parietal resection of papillary muscles, and universal chordal-sparing mitral valve replacement.
Results. There was no in-hospital mortality. The long-term results for up to 5 years show that all patients moved from the IV-III NYHA to I-II NYHA functional classes. Morphological study showed that in the base of myocardial mass increase in HCM there is neither hypertrophy, but hyperplasia of cardiomyocytes. All 16 patients showed significant signs of myxomatous mitral valve degeneration.
Conclusion. Diffuse-generalized type of HCM is due to spread hyperplasia process in myocardium. The invented radical remodeling operation abolishes intraventricular severe changes of pressure and increases diastolic volume of the left ventricle, preventing diastolic dysfunction development.

1. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive summary. J ThoracCardiovascSurg 2011,142,6:1303-38.

2. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).Authors/Task Force members. Eur Heart J. 2014 Oct 14; 35(39): 2733-79.

3. Klues HG, Schiffers A, Maron BJ. Phenotypicspectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;1699-708.

4. Smedira NG, Lytle BW, Lever HM, et al. Current effectiveness and risks of isolated septalmyectomy for hypertrophic obstructive cardiomyopathy. Ann Thoracsurg 2008; 85:127-34.

5. Zaklyazminskaya EV. Genetic diversity of the causes of myocardial hypertrophy. Clinical and Experimental Surgery. Journal by Acad. BV Petrovsky 2014; 1: 23-8. Russian (Заклязьминская Е.В. Генетическое разнообразие причин гипертрофии миокарда. Клиническая и экспериментальная хирургия. Журнал им. акад. Б.В.Петровского 2014; 1:23-8).

6. Wigle ED, Sosson Z, Henderson MA, et al. Hypertrophic cardiomyopathy. The importance ofthe site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 1985; 28(1): 1-85. Raskin W, FrolovaYV, Malikova MS, et al. Surgical treatment of patients with generalized form of obstructive hypertrophic cardiomyopathy. Clinical and Experimental Surgery.

7. Journal by Acad. BV Petrovsky 2014; 1: 100-3. Russian (РаскинВ.В., Фролова Ю. В., Маликова М.С., и др. Тактика хирургического лечения пациентов с генерализованной формой обструктивной гипертрофической кардиомиопатии. Клиническая и экспериментальная хирургия. Журнал имени академика Б.В. Петровского. 2014; 1:100-3).

8. Schaff HV, Said SM. Transaortic Extended SeptalMyectomy for Hypertrophic Cardiomyopathy. Operative Technique in Thoracic and Cardiovascular Surgery 2012, 17,4,238-51.

9. Schaff HV, Dearani JA, Ommen SR, et al. Expanding the indications for septalmyectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction. J Thorac Cardiovasc Surg. 2012; 143(2): 303-9.

10. Gutermann H, Pettinari M, Van Kerrebroeck C, et al. Myectomy and mitral repair through the left atrium in hypertrophic obstructive cardiomyopathy: the preferred approach for contemporary surgical candidates? J Thorac Cardiovasc Surg 2014; 147:1833-6.

11. KwonDH, Smedira NG, Thamilarasan M, et al. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation J Thorac Cardiovasc Surg 2010; 140:317-24.

12. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy 125 patients. Am J Cardiol1981; 48:418.